<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We estimated the risk of arrhythmic complications after the use of cardiovascular medications in a prospective study including 123 patients with arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo> and recurrent <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Dispersion characteristics of P wave and QT interval were studied in patients with left ventricular concentric remodeling, concentric <z:mpath ids='MPATH_159'>hypertrophy</z:mpath>, and eccentric <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>The role of therapy with beta-blockers </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="2" ids="35457">ACE inhibitors</z:chebi>, and preductal in the reduction of the risk of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> and <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo> was evaluated </plain></SENT>
</text></document>